Search results for: Hepatocellular
#32791547 2020/08/13 To Up
[Liver transplantation - current trends].There is an ongoing change in the indications of orthotopic liver transplantation (OLT) with non-alcoholic and alcoholic liver disease and hepatocellular carcinoma (HCC) becoming the main indications whereas the numbers of cirrhosis due to chronic viral hepatitis are declining. 6-MONTH ABSTINENCE RULE: : The directive of the German Federal Medical Association requires absolute abstinence from alcohol for at least 6 months. New data show that patients with severe alcoholic hepatitis for the first time who do not show a response to medical treatment may benefit from OLT. For these patients an individual exception for OLT listing can be requested.
Niklas F Aehling, Daniel Seehofer, Thomas Berg96T250ul10 mgEach10
#32791447 2020/07/28 To Up
Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients.Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver carcinoma whose components include both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Indications for liver transplantation for cHCC-CCA remain controversial.
Takashi Ito, Takamichi Ishii, Shinji Sumiyoshi, Satoshi Ogiso, Ken Fukumitsu, Takashi Ito, Shintaro Yagi, Satoru Seo, Koichiro Hata, Kojiro Taura, Shinji Uemoto
1071 related Products with: Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients.
No related Items
#32791397 2020/07/13 To Up
Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.As a continuation of earlier works, a series of novel quinazolinone derivatives (5a-s) were synthesized and evaluated for their in vitro anti-HBV and anti-hepatocellular carcinoma cell (HCC) activities. Among them, compounds 5j and 5k exhibited most potent inhibitory effect on HBV DNA replication in both drug sensitive and resistant (lamivudine and entecavir) HBV strains. Interestingly, besides the anti-HBV effect, compound 5k could significantly inhibit the proliferation of HepG2, HUH7 and SK- cells, with IC values of 5.44, 6.42 and 6.75 μM, respectively, indicating its potential anti-HCC activity. Notably, the in vitro anti-HCC activity of 5k were more potent than that of positive control 5-fluorouracil and sorafenib. Further studies revealed that compound 5k could induce HepG2 cells apoptosis by dose-dependently upregulating Bad and Bax expression and decreasing Bcl-2 and Bcl-xl protein level. Considering the potent anti-HBV and anti-HCC effect, compound 5k might be a promising lead to develop novel therapeutic agents towards HBV infection and HBV-induced HCC.
Jingying Qiu, Qingqing Zhou, Yinpeng Zhang, Mingyu Guan, Xin Li, Yueting Zou, Xuan Huang, Yali Zhao, Wang Chen, Xiaoke Gu
2965 related Products with: Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.100μl100ug100μl100μl100ug Lyophilized100μl100ug Lyophilized100μl20 mg
#32791232 2020/08/10 To Up
Repeated stereotactic body radiotherapy for hepatocellular carcinoma.In clinical practice, it remains unclear whether cirrhotic livers in patients with hepatocellular carcinoma (HCC) can withstand repeated stereotactic body radiotherapy (SBRT). This study aimed to evaluate outcomes and toxicities in such patients.
Takahisa Eriguchi, Nobuhiro Tsukamoto, Nobuko Kuroiwa, Takafumi Nemoto, Takeru Ogata, Yusuke Okubo, Shigeru Nakano, Akitomo Sugawara
No related Items
#32790956 2020/08/13 To Up
Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease.Copeptin is a stable cleavage product of the arginine vasopressin (AVP) precursor and is equimolarly secreted with AVP. We aimed to assess whether copeptin is the surrogate marker for complications related chronic liver disease (CLD) such as ascites, hepatic encephalopathy (HE), portosystemic shunts (PSS) and all causes of mortality in CLD.
Ryuta Shigefuku, Motoh Iwasa, Akiko Eguchi, Yasuyuki Tamai, Kyoko Yoshikawa, Ryosuke Sugimoto, Yoshiyuki Takei
1468 related Products with: Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease.50 UG100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug Lyophilized50ul (1mg/ml)100 ul100ug Lyophilized100ug Lyophilized
#32790935 2020/08/13 To Up
Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence, significance for clinical presentation and disease outcome.The prevalence and clinical significance of extrahepatic autoimmune diseases (EHAID) have not been evaluated in a large cohort of primary biliary cholangitis (PBC).
Cumali Efe, Murat Torgutalp, Ida Henriksson, Fatema Alalkim, Ellina Lytvyak, Hirsh Trivedi, Fatih Eren, Janett Fischer, Maneerat Chayanupatkul, Claudia Coppo, Tugrul Purnak, Luigi Muratori, Mårten Werner, Paolo Muratori, Fredrik Rorsman, Kristina Onnerhag, Emma Nilsson, Alexandra Heurgué-Berlot, Nurhan Demir, David Semela, Murat Kıyıcı, Thomas D Schiano, Aldo J Montano-Loza, Thomas Berg, Ersan Ozaslan, Eric M Yoshida, Alan Bonder, Hanns-Ulrich Marschall, Benedetta Terziroli Beretta-Piccoli, Staffan Wahlin
1477 related Products with: Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence, significance for clinical presentation and disease outcome.500 tests500 tests500 tests500 tests500 tests
No related Items
#32790882 2020/08/13 To Up
Planning Dosimetry for Y Radioembolization with Glass Microspheres: Evaluating the Fidelity of Tc-MAA and Partition Model Predictions.Tc-MAA-SPECT/CT may be used in Y glass microsphere radioembolization treatment planning to assess perfused liver volumes and absorbed dose distributions. The partition model (PM) offers a more detailed planning dosimetry option beyond the single compartment MIRD model more traditionally used in Y radioembolization. As Y radioembolization treatments shift toward activities and doses that aim to achieve tumor eradication, accurate and reliable treatment planning dosimetry for both tumors and normal liver (NL) becomes more critical. In this work, we explore the accuracy and precision of Y dosimetry predictions from pre-therapy Tc-MAA and PM.
M Allan Thomas, Armeen Mahvash, Mohamed Abdelsalam, Ahmed O Kaseb, S Cheenu Kappadath
2631 related Products with: Planning Dosimetry for Y Radioembolization with Glass Microspheres: Evaluating the Fidelity of Tc-MAA and Partition Model Predictions.10 100ug 100ul4 Arrays/SlideOne 96-Well Microplate Ki100 ug 100 G100 μg1 Set10100ug
#32790866 2020/08/13 To Up
Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancerassociated hepatic stellate cells in hepatocellular carcinoma microenvironment.
Jiang Li, Yan Yan, Lin Ang, Xiaoya Li, Chunying Liu, Bin Sun, Xuejing Lin, Zhangxiao Peng, Xiaofeng Zhang, Qin Zhang, Hongping Wu, Min Zhao, Changqing Su
1032 related Products with: Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancerassociated hepatic stellate cells in hepatocellular carcinoma microenvironment.-1x10e7 cells96 wells96 tests1.00 flask4 x 96-well plate
No related Items
#32790728 2020/08/13 To Up
Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals.Direct-acting antivirals (DAAs) against hepatitis C virus (HCV) exert high anti-HCV activity and are expected to show anti-inflammatory effects associated with HCV elimination. Furthermore, hepatocellular carcinoma (HCC) is known to dedifferentiate from hypovascular tumors, such as dysplastic nodules or well-differentiated HCC, to hypervascular tumors. We therefore explored whether or not DAAs can suppress the growth and hypervascularization of hypovascular tumors.
Kazuaki Tabu, Seiichi Mawatari, Kohei Oda, Kotaro Kumagai, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Kunio Fujisaki, Dai Imanaka, Takeshi Kure, Ohki Taniyama, Ai Toyodome, Sho Ijuin, Haruka Sakae, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido
1363 related Products with: Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals.100ug Lyophilized100ug Lyophilized100ug100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug100ug Lyophilized
#32790706 2020/08/13 To Up
Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma.Disease-associated healthcare expenditures are generally calculated using matched comparisons or regression-based analyses, but little is known about their differences in estimates. This aim of this study was to compare the differences between disease-associated healthcare expenditures estimated using these 2 methods.
Haruhisa Fukuda, Daisuke Sato, Kensuke Moriwaki, Haku Ishida
2423 related Products with: Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma.100
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
Schweiz Züri +41435006251
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
GENTAUR Nederland BV
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
53 Iskar Str. 1191 Kokalyane, Sofia